Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2. Touret F, Driouich JS, Cochin M, Petit PR, et al. Antiviral Res 2021;193:105137.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Touret F, Driouich JS, Cochin M, Petit PR, et al. Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2. Antiviral Res 2021;193:105137.
PMID: 34265358